Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights.
Caputo F, Santini C, Bardasi C, Cerma K, Casadei-Gardini A, Spallanzani A, Andrikou K, Cascinu S, Gelsomino F. Caputo F, et al. Among authors: bardasi c. Int J Mol Sci. 2019 Oct 28;20(21):5369. doi: 10.3390/ijms20215369. Int J Mol Sci. 2019. PMID: 31661924 Free PMC article. Review.
Optimizing the Continuum of Care in Gastric Cancer.
Riccò B, Martinelli G, Bardasi C, Dominici M, Spallanzani A, Salati M. Riccò B, et al. Among authors: bardasi c. Onco Targets Ther. 2023 Nov 23;16:995-1012. doi: 10.2147/OTT.S365505. eCollection 2023. Onco Targets Ther. 2023. PMID: 38021446 Free PMC article. Review.
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience.
Caputo F, Santini C, Casadei-Gardini A, Cerma K, Bardasi C, Garajovà I, Lattanzi E, Passardi A, Rapposelli IG, Spallanzani A, Salati M, Bonetti LR, Gelmini R, Meduri B, Piccoli M, Pecchi A, Benatti S, Piacentini F, Dominici M, Luppi G, Gelsomino F. Caputo F, et al. Among authors: bardasi c. Future Oncol. 2022 Aug;18(24):2651-2659. doi: 10.2217/fon-2021-1646. Epub 2022 Jul 6. Future Oncol. 2022. PMID: 35791815
Exceptional response to lurbinectedin and irinotecan in BRCA-mutated platinum-resistant ovarian cancer patient: a case report.
Cortesi L, Venturelli M, Barbieri E, Baldessari C, Bardasi C, Coccia E, Baglio F, Rimini M, Greco S, Napolitano M, Pipitone S, Dominici M. Cortesi L, et al. Among authors: bardasi c. Ther Adv Chronic Dis. 2022 Jan 13;13:20406223211063023. doi: 10.1177/20406223211063023. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35070248 Free PMC article.
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience.
Bardasi C, Spallanzani A, Benatti S, Spada F, Laffi A, Antonuzzo L, Lavacchi D, Marconcini R, Ferrari M, Rimini M, Caputo F, Santini C, Cerma K, Casadei-Gardini A, Andrikou K, Salati M, Bertolini F, Fontana A, Dominici M, Luppi G, Gelsomino F. Bardasi C, et al. Endocrine. 2021 Dec;74(3):707-713. doi: 10.1007/s12020-021-02813-y. Epub 2021 Jul 6. Endocrine. 2021. PMID: 34231124